drugset / Trial / NCT03198676
A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production
RandomizedSequentialSingle-blindDiagnostic
Summary
A safety study to compare the effect of two different formulations of PrEP-001 nasal powder when dosed in healthy subjects
Timeline
- Start
- 2017-05-08
- Primary completion
- 2017-05-24
- Completion
- 2017-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PrEP-001 | Unknown | 3.2 mg | Intranasal |
| Comparator | PrEP-001 | Unknown | 6.4 mg | Intranasal |